Skip to main content
. 2024 Apr 30;25(9):4941. doi: 10.3390/ijms25094941
ACE2 angiotensin-converting enzyme 2
APTT activated partial thromboplastin time
ARDS acute respiratory distress syndrome
AVDS acute vascular distress syndrome
cGMP cyclic guanosine monophosphate
COVID-19 coronavirus disease 2019
CT computed tomography
CTEPH chronic thromboembolic pulmonary hypertension
DECT contrast dual-energy CT
DLCO diffusing capacity for carbon monoxide
DVT deep vein thrombosis
ECMO extracorporeal membrane oxygenation
eNOS endothelial nitric oxide synthase
EPCR thrombomodulin and endothelial cell protein C receptor
EPO erythropoietin
ERK extracellular signal-regulated kinase
HbNO 5-α-nitrosyl-hemoglobin
HHV-8 human herpesvirus-8
HIF hypoxia-inducible factor
HIV human immunodeficiency virus
HPV hypoxic pulmonary vasoconstriction
ICU intensive care unit
IL interleukin
INR international normalized ratio
iNOS inducible NO synthase
LA lupus anticoagulant
MCP-1 monocyte chemoattractant protein 1
MEK mitogen-activated protein kinase
NETs neutrophil extracellular traps
NF-kB nuclear factor kappa beta
NO nitric oxide
OPN osteopontin
PAI-1 plasminogen activator inhibitor-1
PAH pulmonary arterial hypertension
PAMPs pathogen-associated molecular patterns
PAP pulmonary arterial pressure
PE pulmonary embolism
PH pulmonary hypertension
PVR pulmonary vascular resistance
RAAS renin–angiotensin–aldosterone system
RHC right heart catheterization
ROS reactive oxygen species
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
SPECT ventilation-perfusion single-photon emission computed tomography (SPECT)
TF tissue factor
TFPI tissue factor pathway inhibitor
uPA urokinase plasminogen activator
uPAR urokinase plasminogen activator receptor
VEGF vascular endothelial growth factor
VTE venous thromboembolic events
vWF von Willebrand factor